Tonix Pharmaceuticals Holding (TNXP) Cash from Operations (2010 - 2026)

Tonix Pharmaceuticals Holding's Cash from Operations history runs 17 years deep, the most recent figure standing at 42318000.0 for Q1 2026.

• On a quarterly basis, Cash from Operations fell 155.25% year-over-year to 42318000.0 in Q1 2026; TTM through Mar 2026 was 125583000.0, a 109.55% decrease from a year earlier, with the FY2025 full-year figure at 99844000.0, down 63.88% from the prior year.
• Cash from Operations declined to 42318000.0 in Q1 2026 per TNXP's latest filing, from 39650000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 9919000.0 in Q2 2024 and bottomed at 42318000.0 in Q1 2026.
• The 5-year median for Cash from Operations is 22340000.0 (2023), against an average of 23714294.12.
• Across the five-year window, Cash from Operations surged 57.55% in 2024 and tumbled 171.02% in 2025, its largest moves.
• Year by year, Cash from Operations stood at 22301000.0 in 2022, then slipped by 0.17% to 22340000.0 in 2023, then jumped by 34.51% to 14630000.0 in 2024, then tumbled by 171.02% to 39650000.0 in 2025, then fell by 6.73% to 42318000.0 in 2026.
• Per Business Quant, the three latest TNXP Cash from Operations figures stand at 42318000.0 (Q1 2026), 39650000.0 (Q4 2025), and 28782000.0 (Q3 2025).